# The Case of a 37‐Year‐Old Woman Presenting With Subacute Weakness and Paresthesias

**Authors:** Peter Pacut, Joy Cannon, Neel Dixit, Qihua Fan

PMC · DOI: 10.1002/acn3.70289 · Annals of Clinical and Translational Neurology · 2025-12-17

## TL;DR

A 37-year-old woman with subacute weakness and paresthesias was diagnosed with acute intermittent porphyria, highlighting the importance of early detection for better outcomes.

## Contribution

This case emphasizes the need to consider acute intermittent porphyria in patients with subacute neuropathy and related symptoms.

## Key findings

- The patient exhibited progressive bilateral upper extremity weakness and paresthesias followed by lower extremity involvement.
- Elevated urinary porphobilinogen and aminolevulinic acid levels confirmed acute intermittent porphyric neuropathy.
- A variant of uncertain significance in the HMBS gene was identified, supporting the diagnosis.

## Abstract

Acute intermittent porphyria (AIP) is a rare metabolic disorder that may present with subacute neuropathy and systemic symptoms, often leading to diagnostic delay. We report a 37‐year‐old woman with eight weeks of progressive bilateral upper extremity weakness and paresthesias, followed by lower extremity involvement and falls, in the setting of chronic abdominal pain, presyncope, weight loss, and neuropsychiatric symptoms. Examination revealed profound proximal arm weakness, sensory deficits, bulbar involvement, and autonomic features. MRI of the brain and spine and cerebrospinal fluid analysis were normal. Electrodiagnostic studies demonstrated a severe diffuse motor neurogenic process. Markedly elevated urinary porphobilinogen and aminolevulinic acid levels confirmed the diagnosis of acute intermittent porphyric neuropathy, supported by identification of a variant of uncertain significance in the HMBS gene. This case underscores the importance of considering AIP in patients with subacute motor‐predominant neuropathy accompanied by abdominal pain and autonomic dysfunction, as early diagnosis enables timely treatment and improved outcomes.

## Linked entities

- **Genes:** HMBS (hydroxymethylbilane synthase) [NCBI Gene 3145]
- **Diseases:** acute intermittent porphyria (MONDO:0008294)

## Full-text entities

- **Genes:** HMBS (hydroxymethylbilane synthase) [NCBI Gene 3145] {aka ENCEP, LENCEP, PBG-D, PBGD, PORC, UPS}
- **Diseases:** Paresthesias (MESH:D010292), sensory deficits (MESH:D012678), autonomic dysfunction (MESH:D001342), metabolic disorder (MESH:D008659), weight loss (MESH:D015431), neuropsychiatric symptoms (MESH:D001523), abdominal pain (MESH:D015746), AIP (MESH:D017118), neuropathy (MESH:D009422), Weakness (MESH:D018908)
- **Chemicals:** porphobilinogen (MESH:D011162), aminolevulinic acid (MESH:D000622)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968430/full.md

## References

3 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968430/full.md

---
Source: https://tomesphere.com/paper/PMC12968430